Amgen Inc.

AMGN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2009 FY2008
Assets
Cash & Equivalents $2.88B $1.77B
Accounts Receivable $2.11B $2.07B
Inventory $2.22B $2.08B
Total Current Assets $18.93B $15.22B
Property, Plant & Equipment $5.74B $5.88B
Goodwill $11.34B $11.34B
Intangible Assets (Excl. Goodwill) $2.57B $2.99B
Total Assets $39.63B $36.43B
Liabilities
Accounts Payable $574.0M $504.0M
Total Current Liabilities $3.87B $4.89B
Long-Term Debt $10.60B —
Total Liabilities $16.96B $15.54B
Stockholders' Equity
Retained Earnings $-4.32B $-5.67B
Total Stockholders' Equity $22.67B $20.89B
← Newer Page 3 of 3 Older →